» Articles » PMID: 15805179

Sex Differences in Factors Associated with Childhood- and Adolescent-onset Wheeze

Overview
Specialty Critical Care
Date 2005 Apr 5
PMID 15805179
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Factors predicting the development of wheeze may differ between sexes and between childhood and adolescence.

Methods: A New Zealand birth cohort of 1,037 children was followed to age 26. For this analysis, those reporting recurrent wheezing at two or more assessments were classified as "wheezers." We examined risk factors for development of wheeze before age 10 (childhood) and subsequently (adolescent-onset) for males and for females separately using Cox regression modeling.

Results: Males more often developed childhood wheeze (p = 0.002) and females adolescent-onset wheeze (p < 0.001). Maternal atopy (asthma or hay fever) was a risk factor for childhood wheeze in both sexes (hazard ratio [HR], 1.48, p < 0.05 for males; HR, 2.37, p < 0.001 for females). Paternal atopy also influenced childhood wheeze, significantly for males (HR, 1.72; p = 0.01), and similarly but not significantly for females (HR, 1.70; p = 0.08). For adolescent-onset wheeze, neither maternal (HR, 1.41; p = 0.19) nor paternal history (HR, 0.73; p = 0.42) was a risk factor in males, but maternal history (HR, 2.08; p < 0.01) was a significant risk factor for females. When both age ranges were combined, providing greater power for analysis, paternal history was a stronger risk factor for wheeze in females (HR, 1.62; p = 0.02) than in males (HR, 1.35; p = 0.12).

Conclusion: The influence of parental atopy on the development for wheeze differs between males and females and between childhood- and adolescent-onset wheeze.

Citing Articles

Maternal stressful life events during pregnancy and childhood asthma and wheeze.

Adgent M, Buth E, Norona-Zhou A, Szpiro A, Loftus C, Moore P Ann Allergy Asthma Immunol. 2023; 132(5):594-601.e3.

PMID: 38122928 PMC: 11069451. DOI: 10.1016/j.anai.2023.12.015.


Transcriptomics analysis of allergen-induced inflammatory gene expression in the Four-Core Genotype mouse model.

Ekpruke C, Alford R, Rousselle D, Babayev M, Sharma S, Commodore S Physiol Genomics. 2023; 56(2):235-245.

PMID: 38047309 PMC: 11281817. DOI: 10.1152/physiolgenomics.00112.2023.


IL-33 induces NF-κB activation in ILC2 that can be suppressed by and 17β-estradiol.

Trivedi S, Labuz D, Deering-Rice C, Kim C, Christensen H, Aamodt S Front Allergy. 2022; 3:1062412.

PMID: 36506643 PMC: 9732027. DOI: 10.3389/falgy.2022.1062412.


Sex differences in febrile children with respiratory symptoms attending European emergency departments: An observational multicenter study.

Tan C, El Ouasghiri S, von Both U, Carrol E, Emonts M, van der Flier M PLoS One. 2022; 17(8):e0271934.

PMID: 35921337 PMC: 9348645. DOI: 10.1371/journal.pone.0271934.


Sex Differences in Airway Remodeling and Inflammation: Clinical and Biological Factors.

Ekpruke C, Silveyra P Front Allergy. 2022; 3:875295.

PMID: 35769576 PMC: 9234861. DOI: 10.3389/falgy.2022.875295.


References
1.
Nicolai T, Illi S, Tenborg J, Kiess W, v Mutius E . Puberty and prognosis of asthma and bronchial hyper-reactivity. Pediatr Allergy Immunol. 2001; 12(3):142-8. DOI: 10.1034/j.1399-3038.2001.0007.x. View

2.
BECKLAKE M, Kauffmann F . Gender differences in airway behaviour over the human life span. Thorax. 1999; 54(12):1119-38. PMC: 1763756. DOI: 10.1136/thx.54.12.1119. View

3.
Kalogeromitros D, Katsarou A, Armenaka M, Rigopoulos D, Zapanti M, Stratigos I . Influence of the menstrual cycle on skin-prick test reactions to histamine, morphine and allergen. Clin Exp Allergy. 1995; 25(5):461-6. DOI: 10.1111/j.1365-2222.1995.tb01078.x. View

4.
Sears M, Burrows B, Flannery E, Herbison G, Holdaway M . Atopy in childhood. I. Gender and allergen related risks for development of hay fever and asthma. Clin Exp Allergy. 1993; 23(11):941-8. DOI: 10.1111/j.1365-2222.1993.tb00279.x. View

5.
Xuan W, Marks G, Toelle B, Belousova E, Peat J, Berry G . Risk factors for onset and remission of atopy, wheeze, and airway hyperresponsiveness. Thorax. 2002; 57(2):104-9. PMC: 1746247. DOI: 10.1136/thorax.57.2.104. View